Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against Mycobacteria

The development of more effective vaccines against Mycobacterium tuberculosis has become a world priority. Previously, we have shown that a recombinant BCG expressing the LTAK63 adjuvant (rBCG-LTAK63) displayed higher protection than BCG against tuberculosis challenge in mice. In order to elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho Dos Santos, Carina, Rodriguez, Dunia, Kanno Issamu, Alex, Cezar De Cerqueira Leite, Luciana, Pereira Nascimento, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227645/
https://www.ncbi.nlm.nih.gov/pubmed/31665996
http://dx.doi.org/10.1080/21645515.2019.1669414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227645/
https://www.ncbi.nlm.nih.gov/pubmed/31665996
http://dx.doi.org/10.1080/21645515.2019.1669414

Ejemplares similares